SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurogen (NRGN) -- Ignore unavailable to you. Want to Upgrade?


To: phbolton who wrote (263)3/6/2000 2:21:00 PM
From: Thomas M.  Read Replies (1) | Respond to of 523
 
biz.yahoo.com

It's interesting that Mark Lampert (BVF Partners) was buying last summer, but was selling this December. That was before the big runup, with the stock around 16. That must mean either a change in strategy in his fund, or a change in his fundamental view of NRGN.

Tom